Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, placebo-controlled, two-period, crossover
study in which approximately 20 subjects with Discoid Lupus Erythematosus will be enrolled to
receive AMG 811 and placebo in one of two sequences (ie, AMG 811 followed by placebo or
placebo followed by AMG 811).